2238 Rodeck Ulrich - Thomas Jefferson University - Thomas Jefferson University

Ulrich Rodeck, MD, PhD

Contact Dr. Rodeck

233 South Tenth Street
Bluemle Life Sciences Building, Suite 409
Philadelphia, PA 19107

(215) 503-5622
(215) 503-5788 fax

Most Recent Peer-reviewed Publications

  1. The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice
  2. Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound
  3. Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine
  4. Skinflammation and drug toxicity-A delicate balance
  5. Skin toxicity of targeted cancer agents: Mechanisms and intervention
  6. Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells
  7. Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma
  8. Integration of investigative dermatology into the global biomedical research enterprise: Past, present, and future
  9. Autoregulation of kinase dephosphorylation by ATP binding to AGC protein kinases
  10. A novel preclinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity
  11. Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity
  12. PET imaging of EGFR expression in nude mice bearing MDA-MB-468, a human breast adenocarcinoma
  13. Differential regulation of p53 function by the N-terminal Np53 and 113p53 isoforms in zebrafish embryos
  14. A novel class of compounds with cutaneous wound healing properties
  15. Progress in epidermolysis bullosa research: Toward treatment and cure
  16. Design and development of masked therapeutic antibodies to limit off-target effects: Application to anti-EGFR antibodies
  17. Nuclear factor κB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos
  18. Tumor necrosis factor-α and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice
  19. Interaction with LC8 is required for Pak1 nuclear import and is indispensable for zebrafish development
  20. Skin toxicity caused by EGFR antagonists-an autoinflammatory condition triggered by deregulated IL-1 signaling?